AAO 2020
11.16.20
Horizon: New Data Build on Growing Evidence Supporting Tepezza Efficacy in Thyroid Eye Disease (TED)Source: Horizon Therapeutics
11.16.20
Innovent Announces the Results of the Phase 1 Clinical Trial of IBI302 for Wet AMD at AAO 2020Source: Innovent Biologics
11.16.20
EyePoint Pharmaceuticals Presents Positive Data of Yutiq and Dexycu in Four Poster Sessions at AAO 2020Source: EyePoint Pharmaceuticals
11.16.20
Clearside Biomedical Announces Data Presentations at the AAO 2020Source: Clearside Biomedical
11.16.20
iSTAR Medical’s Glaucoma Device MINIject Shows Positive One-Year Results in European TrialSource: iSTAR Medical
11.13.20
Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at AAO VirtualSource: Oyster Point Pharma
11.13.20
Apellis Announces Late-Breaking Presentation of Largest Retrospective Database Study in Geographic Atrophy at AAO 2020 VirtualSource: Apellis Pharmaceuticals
11.13.20
Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical StudySource: Gemini Therapeutics
11.13.20
Nanoscope Therapeutics Announces Presentation at the 2020 AAOSource: Nanoscope Therapeutics